351 related articles for article (PubMed ID: 19716789)
1. The F box protein Fbx6 regulates Chk1 stability and cellular sensitivity to replication stress.
Zhang YW; Brognard J; Coughlin C; You Z; Dolled-Filhart M; Aslanian A; Manning G; Abraham RT; Hunter T
Mol Cell; 2009 Aug; 35(4):442-53. PubMed ID: 19716789
[TBL] [Abstract][Full Text] [Related]
2. Targeting the checkpoint kinase Chk1 in cancer therapy.
Merry C; Fu K; Wang J; Yeh IJ; Zhang Y
Cell Cycle; 2010 Jan; 9(2):279-83. PubMed ID: 20023404
[TBL] [Abstract][Full Text] [Related]
3. Glucose deprivation is associated with Chk1 degradation through the ubiquitin-proteasome pathway and effective checkpoint response to replication blocks.
Kim AJ; Kim HJ; Jee HJ; Song N; Kim M; Bae YS; Chung JH; Yun J
Biochim Biophys Acta; 2011 Jun; 1813(6):1230-8. PubMed ID: 21440578
[TBL] [Abstract][Full Text] [Related]
4. Hsp90 inhibitor-mediated disruption of chaperone association of ATR with hsp90 sensitizes cancer cells to DNA damage.
Ha K; Fiskus W; Rao R; Balusu R; Venkannagari S; Nalabothula NR; Bhalla KN
Mol Cancer Ther; 2011 Jul; 10(7):1194-206. PubMed ID: 21566061
[TBL] [Abstract][Full Text] [Related]
5. WRN helicase regulates the ATR-CHK1-induced S-phase checkpoint pathway in response to topoisomerase-I-DNA covalent complexes.
Patro BS; Frøhlich R; Bohr VA; Stevnsner T
J Cell Sci; 2011 Dec; 124(Pt 23):3967-79. PubMed ID: 22159421
[TBL] [Abstract][Full Text] [Related]
6. E2F1 proteolysis via SCF-cyclin F underlies synthetic lethality between cyclin F loss and Chk1 inhibition.
Burdova K; Yang H; Faedda R; Hume S; Chauhan J; Ebner D; Kessler BM; Vendrell I; Drewry DH; Wells CI; Hatch SB; Dianov GL; Buffa FM; D'Angiolella V
EMBO J; 2019 Oct; 38(20):e101443. PubMed ID: 31424118
[TBL] [Abstract][Full Text] [Related]
7. ATR and Chk1 suppress a caspase-3-dependent apoptotic response following DNA replication stress.
Myers K; Gagou ME; Zuazua-Villar P; Rodriguez R; Meuth M
PLoS Genet; 2009 Jan; 5(1):e1000324. PubMed ID: 19119425
[TBL] [Abstract][Full Text] [Related]
8. Dual regulation of Cdc25A by Chk1 and p53-ATF3 in DNA replication checkpoint control.
Demidova AR; Aau MY; Zhuang L; Yu Q
J Biol Chem; 2009 Feb; 284(7):4132-9. PubMed ID: 19060337
[TBL] [Abstract][Full Text] [Related]
9. ATR-mediated checkpoint pathways regulate phosphorylation and activation of human Chk1.
Zhao H; Piwnica-Worms H
Mol Cell Biol; 2001 Jul; 21(13):4129-39. PubMed ID: 11390642
[TBL] [Abstract][Full Text] [Related]
10. Requirement of MTA1 in ATR-mediated DNA damage checkpoint function.
Li DQ; Ohshiro K; Khan MN; Kumar R
J Biol Chem; 2010 Jun; 285(26):19802-12. PubMed ID: 20427275
[TBL] [Abstract][Full Text] [Related]
11. Regulation of ATR-CHK1 signaling by ubiquitination of CLASPIN.
Zhu X; Zheng XY; Gong P; Xu X
Biochem Soc Trans; 2022 Oct; 50(5):1471-1480. PubMed ID: 36196914
[TBL] [Abstract][Full Text] [Related]
12. Autoregulatory mechanisms of phosphorylation of checkpoint kinase 1.
Wang J; Han X; Zhang Y
Cancer Res; 2012 Aug; 72(15):3786-94. PubMed ID: 22855742
[TBL] [Abstract][Full Text] [Related]
13. ATR, Claspin and the Rad9-Rad1-Hus1 complex regulate Chk1 and Cdc25A in the absence of DNA damage.
Sørensen CS; Syljuåsen RG; Lukas J; Bartek J
Cell Cycle; 2004 Jul; 3(7):941-5. PubMed ID: 15190204
[TBL] [Abstract][Full Text] [Related]
14. Ataxin-3 promotes genome integrity by stabilizing Chk1.
Tu Y; Liu H; Zhu X; Shen H; Ma X; Wang F; Huang M; Gong J; Li X; Wang Y; Guo C; Tang TS
Nucleic Acids Res; 2017 May; 45(8):4532-4549. PubMed ID: 28180282
[TBL] [Abstract][Full Text] [Related]
15. The phosphorylated C-terminal domain of Xenopus Cut5 directly mediates ATR-dependent activation of Chk1.
Hashimoto Y; Tsujimura T; Sugino A; Takisawa H
Genes Cells; 2006 Sep; 11(9):993-1007. PubMed ID: 16923121
[TBL] [Abstract][Full Text] [Related]
16. Chk1 C-terminal regulatory phosphorylation mediates checkpoint activation by de-repression of Chk1 catalytic activity.
Walker M; Black EJ; Oehler V; Gillespie DA; Scott MT
Oncogene; 2009 Jun; 28(24):2314-23. PubMed ID: 19421147
[TBL] [Abstract][Full Text] [Related]
17. Ku affects the ataxia and Rad 3-related/CHK1-dependent S phase checkpoint response after camptothecin treatment.
Wang H; Wang X; Zhou XY; Chen DJ; Li GC; Iliakis G; Wang Y
Cancer Res; 2002 May; 62(9):2483-7. PubMed ID: 11980637
[TBL] [Abstract][Full Text] [Related]
18. Replication stress activates DNA polymerase alpha-associated Chk1.
Taricani L; Shanahan F; Parry D
Cell Cycle; 2009 Feb; 8(3):482-9. PubMed ID: 19177015
[TBL] [Abstract][Full Text] [Related]
19. Genotoxic stress targets human Chk1 for degradation by the ubiquitin-proteasome pathway.
Zhang YW; Otterness DM; Chiang GG; Xie W; Liu YC; Mercurio F; Abraham RT
Mol Cell; 2005 Sep; 19(5):607-18. PubMed ID: 16137618
[TBL] [Abstract][Full Text] [Related]
20. Destruction of Claspin by SCFbetaTrCP restrains Chk1 activation and facilitates recovery from genotoxic stress.
Mailand N; Bekker-Jensen S; Bartek J; Lukas J
Mol Cell; 2006 Aug; 23(3):307-18. PubMed ID: 16885021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
